Literature DB >> 8427596

Expression of biologically active human factor VIII using a baculovirus vector.

E Webb1, J Tkalcevic, S Edwards, D Hocking, I Nisbet.   

Abstract

Factor VIII is a complex, plasma glycoprotein involved in the process of blood coagulation. Production of the recombinant molecule has largely been confined to mammalian cell systems which have, in general, proven to be inefficient producers of factor VIII. The use of a baculovirus expression system may provide increased levels of this glycoprotein, although it is not certain that insect cell-derived factor VIII will be biologically active. The N-linked glycosylation patterns in insect cells, until recently thought to be less complex than in mammalian cells, may influence activity and/or secretory ability. To this end we engineered a B domain-deleted factor VIII cDNA sequence for expression in Spodoptera frugiperda cells. The construct retained the native signal sequence to allow secretion of recombinant protein into the culture medium. Initial studies revealed the production of secreted factor VIII, and this protein was shown to possess coagulation activity. The presence of N-linked oligosaccharide residues was demonstrated, the glycosylated molecule being of a similar size to that expressed in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427596     DOI: 10.1006/bbrc.1993.1081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Enhanced secretory ability for the human factor VIII light chain produced in baculovirus-infected insect cells.

Authors:  E Webb; J Tkalcevic; S Edwards; D Hocking; I Nisbet
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

2.  Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells.

Authors:  T Satoh; H Satoh; S Iwahara; Z Hrkal; D H Peyton; U Muller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.